Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Gynecol Oncol. 2015 Apr 16;138(1):24–29. doi: 10.1016/j.ygyno.2015.04.006

Table 3.

Response, 6-month PFS, cycles of treatment and status.

Endpoint Category n %
Off study therapy Cycles of Treatment Yes 28 100.0
1 1 3.6
2 12 42.9
3 3 10.7
4 4 14.3
5 1 3.6
6 3 10.7
8 1 3.6
11 1 3.6
12 2 7.1
Reason off therapy Disease Progression 24 85.7
Patient Refused 1 3.6
Toxicity 2 7.1
Death 1 3.6
RECIST 1.1 Response Complete or partial response 0 0.0
Stable Disease 16 57.1
Disease Progression 11 39.3
Indeterminate 1 3.6
PFS ≥ 6 months No 23 82.1
Yes 5 17.9
TPFS ≥ 6 months No 25 89.3
Yes 3 10.7
Survival status Alive 10 35.7
Dead – Treatment-related 1 3.6
Dead – Disease-related 17 60.7